BioAdvance News

QR Pharma Announces the Start of a Phase I Clinical Study for Bisnorcymserine

By WebmasterJuly 24, 2012November 1st, 2024No Comments

QR Pharma Announces the Start of a Phase I Clinical Study for Bisnorcymserine
Read more here

Previous PostFDA Accepts NuPathe Inc. (PATH)'s Migraine Patch NDA Resubmission for Filing
Next PostQR Pharma Announces Publication on Posiphen Clincial Trials Showing Promise